Publicaciones en las que colabora con ANGELES ALVAREZ RIBELLES (25)

2023

  1. Abacavir causes leukocyte/platelet crosstalk by activating neutrophil P2X7 receptors thus releasing soluble lectin-like oxidized low-density lipoprotein receptor-1

    British Journal of Pharmacology, Vol. 180, Núm. 11, pp. 1516-1532

  2. P2X7 Receptor Regulates Collagen Expression in Human Intestinal Fibroblasts: Relevance in Intestinal Fibrosis

    International Journal of Molecular Sciences, Vol. 24, Núm. 16

2022

  1. Macrophages Modulate Hepatic Injury Involving NLRP3 Inflammasome: The Example of Efavirenz

    Biomedicines, Vol. 10, Núm. 1

2021

  1. Abacavir Increases Purinergic P2X7 Receptor Activation by ATP: Does a Pro-inflammatory Synergism Underlie Its Cardiovascular Toxicity?

    Frontiers in Pharmacology, Vol. 12

2020

  1. Differential Effects of Biologics on Psoriasis-Related Vascular Inflammation and Risk of Thrombosis

    Journal of Investigative Dermatology, Vol. 140, Núm. 11, pp. 2294-2298.e6

  2. Leukocyte–Endothelium Interaction Is Associated with Fat Mass in Children

    Journal of Pediatrics, Vol. 221, pp. 181-187.e1

2018

  1. Abacavir induces arterial thrombosis in a murine model

    Journal of Infectious Diseases

2017

  1. Abacavir induces platelet-endothelium interactions by interfering with purinergic signalling: A step from inflammation to thrombosis

    Antiviral Research, Vol. 141, pp. 179-185

  2. Cardiovascular toxicity of abacavir: A clinical controversy in need of a pharmacological explanation

    AIDS, Vol. 31, Núm. 13, pp. 1781-1795

2016

  1. Aspirin-induced gastrointestinal damage is associated with an inhibition of epithelial cell autophagy

    Journal of Gastroenterology, Vol. 51, Núm. 7, pp. 691-701

  2. Interference with purinergic signalling: An explanation for the cardiovascular effect of abacavir?

    AIDS, Vol. 30, Núm. 9, pp. 1341-1351

2015

  1. Differential effects of anti-TNF-α and anti-IL-12/23 agents on human leukocyte-endothelial cell interactions

    European Journal of Pharmacology, Vol. 765, pp. 355-365

  2. Efavirenz and the CNS: What we already know and questions that need to be answered

    Journal of Antimicrobial Chemotherapy, Vol. 70, Núm. 10, pp. 2693-2708

2014

  1. Efavirenz induces interactions between leucocytes and endothelium through the activation of Mac-1 and gp150,95

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 4, pp. 995-1004

  2. Neuronal bioenergetics and acute mitochondrial dysfunction: A clue to understanding the central nervous system side effects of efavirenz

    Journal of Infectious Diseases, Vol. 210, Núm. 9, pp. 1385-1395

  3. Progastrin represses the alternative activation of human macrophages and modulates their influence on colon cancer epithelial cells

    PLoS ONE, Vol. 9, Núm. 6

2013

  1. M2 Macrophages Activate WNT Signaling Pathway in Epithelial Cells: Relevance in Ulcerative Colitis

    PLoS ONE, Vol. 8, Núm. 10

  2. Profile of leukocyte-endothelial cell interactions induced in venules and arterioles by nucleoside reverse-transcriptase inhibitors in vivo

    Journal of Infectious Diseases

2012

  1. Differential effects of tenofovir/emtricitabine and abacavir/lamivudine on human leukocyte recruitment

    Antiviral Therapy, Vol. 17, Núm. 8, pp. 1615-1619

2010

  1. Abacavir and didanosine induce the interaction between human leukocytes and endothelial cells through Mac-1 upregulation

    AIDS, Vol. 24, Núm. 9, pp. 1259-1266